FOLH1 and neoplasm: Besides receptor-mediated mechanisms, small-molecule ligand-antigen interaction-based targeting is also an effective tumor-targeting strategy, such as the inhibition effect between (S)-5-amino-1-carboxypentyl)carbamoyl)-L-glutamic acid (Glu-urea-Lys) and prostate-specific membrane antigen (PSMA).